ClinicalTrials.gg
Drug

Imetelstat clinical trials

Also written GRN163L.

studies test it
25
open now
4
in phase 3
2
first study started
2005

How each study uses imetelstat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the imetelstat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
6 Jun 2024 · RYTELO · NDA 217779 (FDA, Drugs@FDA)
European Union
7 Mar 2025 · Rytelo · EMEA/H/C/006105 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Imetelstat
10
Imetelstat sodium
6
Imetelstat Sodium (GRN163L)
4

Development codes

GRN163L
13

Studies by the year they started

23 studies that test it; most in 2010 (3); 2 more planned to start later

Studies that test imetelstat, by start year
YearStudies
20051
20061
20072
20082
20103
20112
20122
20132
20141
20151
20161
20211
20221
20231
20251
20261

Who runs them

Industry 15 · Other 10

Geron Corporation (14) · Children's Oncology Group (3) · GCP-Service International West GmbH (1) · Indiana University (1) · M.D. Anderson Cancer Center (1) · University of Wisconsin, Madison (1) · Douglas Tremblay (1) · Pediatric Brain Tumor Consortium (1)

Often tested with

Tested in the same studies.

Ruxolitinib (1) · Cytarabine (1) · Fludarabine (1) · Azacitidine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test imetelstat.

Studies

Open first, then newest update. How each study uses imetelstat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test imetelstat →

Given beside what is tested · 1 — imetelstat is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call imetelstat · ClinicalTrials.gg INT005080

  • MeSH (NLM) C519562imetelstatConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) F60NE4XB53IMETELSTATConfirmed FDA, NLM, Wikidata
  • Wikidata Q21083935imetelstatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C49084ImetelstatOne source FDA
  • DrugBank DB14909One source Wikidata

Also registered as imetelstat sodium (UNII 2AW48LAZ4I).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.